The discrepancy between the levels of Gal-4 in the tumor tissues and in the blood sera of patients can be explained by the extensive production of circulating Gal-4 by many other types of cell, such as peritumoral stromal cells and a variety of immune cells [15]. Here, LGALS4 is linked to neoplasm.